Articles tagged with Affective Disorders
A systematic review of social media platforms reveals that TikTok contains a substantial proportion of misleading information about mental health and neurodivergence, with higher rates of misinformation than other platforms. The study emphasizes the importance of credible sources and evidence-based content to combat spreading false ide...
Dr. Phillips's laboratory identifies abnormalities in prefrontal-striatal-limbic circuitry as biomarkers for bipolar disorder before symptoms appear. Her team tracks neural network development from infancy through young adulthood.
A cohort study found that adverse childhood experiences (ACEs) were associated with an increased risk of treatment-resistant depression in adults. Preventing ACEs and incorporating ACE history into clinical assessment may help identify individuals at elevated risk for treatment resistance.
Emerging research across conceptual frameworks, biomarker science, digital phenotyping, and artificial intelligence synthesizes a translational pathway toward a more biologically grounded and clinically useful approach to psychiatric diagnosis. The current system falls short due to standardized clinical language and lack of biological ...
A new study models brain aging and resilience over the lifespan, uncovering individual factors that affect cognition and identifying potential biomarkers of healthy brain aging. Researchers are now incorporating diverse data, including social and lifestyle factors, to create a broader picture of the aging brain.
A decision-support system improved depressive and anxiety symptoms, increased medication adherence, and reduced symptoms over time for patients with major depressive disorder. The system used clinical and demographic predictors to tailor treatment, resulting in better outcomes for patients compared to usual care.
Researchers found that a condensed brain stimulation therapy, known as '5x5' TMS, produced comparable results to the standard six-week course of treatment. Patients who showed little improvement immediately after finishing their five-day course still benefited significantly in the weeks that followed.
China's youth faces a growing mental health crisis, but AI platforms like DeepSeek offer promising solutions to bridge the gap. These platforms leverage natural language processing and generative AI to provide round-the-clock support tailored to Chinese society.
The study reveals that the paraventricular thalamic nucleus (PVT) is the central pathological substrate of bipolar disorder, with notable alterations in cell number and gene expression. This discovery highlights the PVT as a potential diagnostic and therapeutic target for improving patient outcomes.
Dissociation is a complex survival mechanism in response to overwhelming trauma, affecting memory, identity, and perception. Research confirms its prevalence among individuals who have experienced trauma, and effective dissociation-specific treatment options are needed.
The updated edition provides a comprehensive overview of major mental health conditions that emerge during adolescence, discussing treatment strategies and prevention methods. The book emphasizes the importance of addressing stigma, promoting evidence-based treatments, and integrating positive youth development into policy agendas.
A Dartmouth study identifies a novel target for using psilocybin to treat depression and anxiety without hallucinations. The serotonin 1B receptor is found to promote the therapeutic benefits of psilocybin, providing a potential new approach for developing safer and more cost-efficient medications.
A Cochrane review found that exercise can reduce depressive symptoms similarly to psychological therapy, with moderate-certainty evidence from ten trials. Long-term effects are unclear due to few studies following participants after treatment.
Scientists at Salk Institute find protein CCN1, secreted by astrocytes, maintains stable neural circuits in adult brains. The discovery could lead to new therapeutics for brain injury and stroke.
A new study suggests that midlife depression is driven by a small cluster of specific symptoms, rather than depression overall. The six symptoms are loss of self-confidence, difficulty coping with problems, and poor concentration, which can lead to reduced social engagement and decreased cognitive reserve.
Teenagers who struggle with their bodies are at risk of developing eating disorders and depression in early adulthood, according to a new study. The research, which followed over 2,000 twins, found that body dissatisfaction at age 16 predicted greater symptoms of mental health issues well into the twenties.
A subset of depressed individuals with chronic, low-grade inflammation may benefit from anti-inflammatory treatment, according to a systematic review and meta-analysis. The study found that anti-inflammatory medications significantly reduced depressive symptom severity and anhedonia in these patients.
A new study by researchers in Canada and Italy suggests that young adolescents who participated in organized sports between ages 6 and 10 are less likely to defy authority figures. The study found that structured extracurricular activities can promote behavioral resilience and reduce the burden of disruptive behavior disorders.
Dr. Paul Lucassen's research on adult neurogenesis reveals the link between early life experiences, lifestyle factors, and depression/dementia risk. His work has implications for therapeutic approaches to brain health and disease.
A major meta-analysis found that nitrous oxide can offer fast-acting depressive symptom relief for adults with major depressive disorder and treatment-resistant depression. The study showed significant improvements in mood within 24 hours, but repeated dosing over several weeks was needed to sustain clinical benefit.
Researchers at the University of Plymouth have successfully used transcranial ultrasound stimulation (TUS) to change the function of a deep region of the human brain, specifically the nucleus accumbens. This tiny element is triggered by enjoyable experiences and helps us learn behaviours that lead to rewards.
Researchers found that a protein involved in ATP release, connexin 43, plays a key role in depressive- and anxiety-like behaviors. Restoring connexin 43 in the hippocampus improved behavioral outcomes and boosted ATP levels in stressed mice.
A cross-sectional study found that US population faces significant challenges with nervous system disorders, impacting 180.3 million people, mainly due to stroke, Alzheimer's disease, diabetic neuropathy, and migraine conditions.
The article highlights the mismatch between psychedelics and economic drug development principles. Pharmaceutical companies are developing short-acting compounds and neuroplastogens to engineer trips out of the experience altogether. Dr. Sandy Hager's research suggests investors should remain cautious due to weak intellectual property ...
A new study published in the Hypertension Journal found that chronic pain in adults may increase their risk of developing high blood pressure, with depression playing a significant role. The study analyzed data from over 200,000 adults and found that widespread pain was associated with a higher risk of high blood pressure.
Researchers propose a closed-loop system combining peripheral nerve stimulation (PNS) with brain-computer interfaces (BCIs) to personalize neuromodulation. This approach aims to address treatment-resistant depression and schizophrenia by dynamically tailoring interventions to individual neural signatures.
A recent landmark study identifies adenosine as the critical mediator of rapid antidepressant action, connecting ketamine, ECT, and hypoxia. The discovery raises questions about the potential interference of caffeine with these treatments, highlighting the need for further research on adenosinergic modulation in depression.
A new analysis of the PANDA trial found that sertraline contributes to improvements in low mood and suicidal thinking within two weeks of taking the drug. The study also revealed an improvement in emotional symptoms of depression within two weeks, with continued benefits from six weeks to 12 weeks.
The BD² Discovery Research program awards $18 million to researchers exploring the neural circuitry of bipolar disorder. This funding enables the development of innovative treatment approaches and accelerates better care for those living with the condition.
Researchers found that impaired maternal care and increased stress hormone signaling led to health, behavioral, and attachment issues in mouse pups. Long-term stunted growth trajectories and anxiety-like behavior were observed after just 1 week of limited bedding.
Researchers identified a genetic inflammatory signature that defines specific depression subtypes and influences antidepressant outcomes. Higher CRP polygenic scores were associated with reduced weight and appetite loss, earlier age of onset, and lower employment status after treatment.
Dr. Amin's transformative insights reshape international understanding of depression genetics, identifying novel therapeutic targets and biomarkers for diagnosis and treatment. Her systemic disease model challenges traditional views of depression as a brain disorder.
Researchers have identified a rapid physiological marker that predicts which patients with major depression will respond to magnetic brain stimulation therapy. Patients whose heart rates slowed within 45 seconds of starting treatment showed significantly greater improvement in depressive symptoms six weeks later.
A study of 5,794 adults found that different types of depression are associated with varying levels of risk for cardiometabolic diseases. Those with atypical/energy-related symptoms were more likely to develop Type-2 diabetes, while those with melancholic symptoms were at higher risk for cardiovascular disease.
A renowned geneticist, Dr. Martin Alda, has made a groundbreaking discovery that bipolar disorder is composed of multiple genetically distinct disorders, transforming treatment approaches worldwide. His research also highlights the importance of combining basic research with clinical observations to advance psychiatric care.
Researchers identify abnormal sugar modifications linked to depressive behaviors, offering potential diagnostic and therapeutic targets. Chronic stress disrupts sugar chains in the prefrontal cortex, triggering depression.
The latest October issues of APA journals feature new research on adolescent suicidality and depression, premenstrual dysphoric disorder (PMDD), and safety issues related to ketamine and esketamine treatment. The American Journal of Psychotherapy also publishes a special issue on intensive short-term dynamic psychotherapy (ISTDP).
Research in African populations aims to understand the link between depression and hypertension, two conditions affecting millions worldwide. The study will focus on identifying shared genetic mechanisms, which could lead to more effective treatment strategies for complex diseases.
Dr. Gerhard Andersson's pioneering work in internet-delivered cognitive behavioral therapy has produced over 200 controlled trials and transformed mental healthcare accessibility across continents.
Professor Siegfried Kasper reveals biological bases of psychiatric disorders alongside psychosocial determinants, influencing treatment protocols globally. His pioneering research transformed approaches to treatment-resistant depression, improving millions of lives.
Professor Gregor Hasler's pioneering research reveals how psychedelics like LSD, psilocybin, and MDMA enhance neuroplasticity, allowing the brain to rewire itself and break free from depression, PTSD, and addiction. His discoveries have the potential to fundamentally alter international approaches to mental health treatment.
Researchers found that individuals with more severe depressive symptoms had difficulty learning to actively avoid aversive sounds, but their ability improved once they mastered the task. The study suggests that depressive symptoms may specifically interfere with learning to avoid unpleasant events rather than avoidance in general.
A computational framework has been created to understand how the brain's striatum region influences everyday decisions and impaired decision-making in individuals with psychiatric disorders. The study suggests that modulating striosomal activity could be a new approach to addressing psychiatric abnormalities.
Folate and biopterin cofactors modulate disease mechanisms through shared enzymatic pathways and structural similarities. Key interactions include BH₄ salvage, enzyme substitution, and CNS folate-biopterin axis, highlighting the importance of their crosstalk in diseases such as depression, autism, and vascular disease.
Researchers found that older adults who challenge themselves to learn new things are less likely to experience loneliness or depression, even during the COVID-19 pandemic. Continued skill learning is associated with improved mental health outcomes, including greater resilience to external stressors and reduced depressive symptoms.
Dr. David Rubinow's research reveals that susceptible women respond differently to normal hormonal fluctuations, leading to breakthrough treatment approaches and FDA-approved medication for postpartum depression. His work validates the experiences of millions of women whose hormone-related mood symptoms were previously misunderstood.
Researchers at the Institute for Basic Science have discovered that excessive GABA produced by astrocytes impairs fear extinction in PTSD. A new brain-permeable drug called KDS2010 has reversed PTSD-like symptoms in mice, providing a promising therapeutic approach.
The EmoWELL video game has been shown to improve emotional management in young university students by helping them identify, understand, and manage their emotions. Participants who played the game demonstrated reduced use of strategies that worsen emotional distress and improved self-acceptance.
A new study found that older adults with insomnia face triple the risk of developing depressive symptoms compared to sound sleepers. The study suggests that treatments targeted at inflammation-related depression may benefit these patients and improve their overall quality of life.
Researchers at the Salk Institute have identified a brain circuit that gives physical pain its emotional tone, revealing a potential target for treating chronic and affective pain conditions. The study found that a group of neurons in the thalamus can mediate the emotional side of pain in mice.
Dr. Danielle Beckman's research uses animal models to understand how viruses like COVID-19 trigger neurological damage and accelerate Alzheimer's disease. Her work has established critical connections between viral infections and neurodegenerative processes.
Researchers developed an individualized TMS targeting algorithm using large-scale brain imaging data to enhance treatment outcomes in depression. This approach, called MDD big data-guided individualized TMS targeting algorithm, produced targets more closely associated with symptom improvement.
A new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging found that individuals with remitted depression show increased habenula activity and reduced connectivity between the habenula and dopamine-producing regions, suggesting a heightened sensitivity to negative cues. This suggests that even after recove...
Research synthesizes evidence from dozens of studies on polygenic scores and their clinical implications, revealing consistent patterns that could contribute to personalized psychiatric care. Higher genetic risk for depression correlates with poorer treatment outcomes, including nonresponse to antidepressants and mood stabilizers.
A new study from the University of Pittsburgh suggests that excessive screen time and poor sleep quality may contribute to teen depression. The research found that teens who spent more time on screens and got less sleep had weaker brain connections, which can affect emotion regulation, memory, and attention.
Dr. Stephen Ross's groundbreaking studies using psilocybin therapy have demonstrated rapid, substantial, and sustained improvements in psychological symptoms for patients with advanced cancer, substance use disorders, and major depressive disorder. His research has the potential to challenge conventional psychiatric medication approaches.
Research found that approximately 50% of participants with late-life depression and bipolar disorder showed tau accumulation in their brains, compared to only about 15% of healthy controls. The study suggests that neurodegenerative diseases, including Alzheimer's, can initially manifest as psychiatric symptoms.
A recent study by Luiza Cesar Riani Costa and Diene Monique Carlos has provided insights into non-suicidal self-harm among adolescents. The booklet, featuring photographs and experiences of young people, offers a low-cost therapeutic and educational tool to address mental health concerns.
A comprehensive review reveals that early ECT sessions show substantial improvement, but subsequent sessions may lead to diminishing returns and cognitive side effects. The researchers propose a response-guided sequential treatment strategy, categorizing patients into three groups based on their response patterns.
Professor Benedetti's research explores the intersection of genetics, environmental factors, and treatment response in mood disorders. His work has led to breakthroughs in chronotherapeutics and immuno-psychiatry, revealing crucial insights into immune-inflammatory mechanisms and gene variants influencing brain function.